Peptic ulcer disease and non-steroidal anti-inflammatory drugs

Musa Drini*

*Corresponding author for this work

    Research output: Contribution to journalArticlepeer-review

    142 Citations (Scopus)

    Abstract

    Non-steroidal anti-inflammatory drugs including low-dose aspirin are some of the most commonly used medicines. They are associated with gastrointestinal mucosal injury. Before prescribing, it is important to assess the patient’s gastrointestinal risk factors such as age and history of peptic ulcers. Patients at high risk may require co-prescription to reduce the risk of peptic ulcers. A daily dose of a proton pump inhibitor is the most effective method of reducing the risk of ulcers induced by non-steroidal anti-inflammatory drugs.

    Original languageEnglish
    Pages (from-to)91-93
    Number of pages3
    JournalAustralian Prescriber
    Volume40
    Issue number3
    DOIs
    Publication statusPublished - 2017

    Fingerprint

    Dive into the research topics of 'Peptic ulcer disease and non-steroidal anti-inflammatory drugs'. Together they form a unique fingerprint.

    Cite this